Neuroprotection and Immunomodulation by Xenografted Human Mesenchymal Stem Cells Following Spinal Cord Ventral Root Avulsion

Overview

Journal Sci Rep

Specialty Science

Date 2015 Nov 10

PMID 26548646

Citations 35

Authors

Thiago B Ribeiro

Adriana S S Duarte

Ana Leda F Longhini

Fernando Pradella

Alessandro S Farias

Angela C M Luzo

Alexandre L R Oliveira

Sara Teresinha Olalla Saad

Affiliations

Soon will be listed here.

Abstract

The present study investigates the effects of xenotransplantation of Adipose Tissue Mesenchymal Stem Cells (AT-MSCs) in animals after ventral root avulsion. AT-MSC has similar characteristics to bone marrow mesenchymal stem cells (BM-MSCs), such as immunomodulatory properties and expression of neurotrophic factors. In this study, Lewis rats were submitted to surgery for unilateral avulsion of the lumbar ventral roots and received 5 × 10(5) AT-MSCs via the lateral funiculus. Two weeks after cell administration, the animals were sacrificed and the moto neurons, T lymphocytes and cell defense nervous system were analyzed. An increased neuronal survival and partial preservation of synaptophysin-positive nerve terminals, related to GDNF and BDNF expression of AT-MSCs, and reduction of pro-inflammatory reaction were observed. In conclusion, AT-MSCs prevent second phase neuronal injury, since they suppressed lymphocyte, astroglia and microglia effects, which finally contributed to rat motor-neuron survival and synaptic stability of the lesioned motor-neuron. Moreover, the survival of the injected AT- MSCs lasted for at least 14 days. These results indicate that neuronal survival after lesion, followed by mesenchymal stem cell (MSC) administration, might occur through cytokine release and immunomodulation, thus suggesting that AT-MSCs are promising cells for the therapy of neuronal lesions.

Citing Articles

Administration of Human-Derived Mesenchymal Stem Cells Activates Locally Stimulated Endogenous Neural Progenitors and Reduces Neurological Dysfunction in Mice after Ischemic Stroke.

Fujiwara S, Nakano-Doi A, Sawano T, Kubo S, Doe N, Nakagomi T Cells. 2024; 13(11.

PMID: 38891071 PMC: 11171641. DOI: 10.3390/cells13110939.

ROS-responsive nanoparticle delivery of ferroptosis inhibitor prodrug to facilitate mesenchymal stem cell-mediated spinal cord injury repair.

Hua R, Zhao C, Xu Z, Liu D, Shen W, Yuan W Bioact Mater. 2024; 38:438-454.

PMID: 38770428 PMC: 11103787. DOI: 10.1016/j.bioactmat.2024.05.015.

Embryonic stem cells overexpressing high molecular weight FGF2 isoform enhance recovery of pre-ganglionic spinal root lesion in combination with fibrin biopolymer mediated root repair.

Lima B, Cartarozzi L, Kyrylenko S, Ferreira Jr R, Barraviera B, Oliveira A Stem Cell Res Ther. 2024; 15(1):63.

PMID: 38438875 PMC: 10913678. DOI: 10.1186/s13287-024-03676-6.

Exosomes derived from CD271CD56 bone marrow mesenchymal stem cell subpopoulation identified by single-cell RNA sequencing promote axon regeneration after spinal cord injury.

Sun Y, Liu Q, Qin Y, Xu Y, Zhao J, Xie Y Theranostics. 2024; 14(2):510-527.

PMID: 38169566 PMC: 10758065. DOI: 10.7150/thno.89008.

Reprogramming by Cytosolic Extract of Human Embryonic Stem Cells to Improve Dopaminergic Differentiation Potential of Human Adipose Tissue-derived Stem Cells.

Mobasseri S, Javeri A, Taha M Basic Clin Neurosci. 2022; 13(2):247-255.

PMID: 36425950 PMC: 9682313. DOI: 10.32598/bcn.12.6.2069.1.

References

Seo J, Kim H, Park E, Lee J, Kim D, Kim H . Environmental enrichment synergistically improves functional recovery by transplanted adipose stem cells in chronic hypoxic-ischemic brain injury. Cell Transplant. 2013; 22(9):1553-68. DOI: 10.3727/096368912X662390. View

Crigler L, Robey R, Asawachaicharn A, Gaupp D, Phinney D . Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 2005; 198(1):54-64. DOI: 10.1016/j.expneurol.2005.10.029. View

Kota D, Wiggins L, Yoon N, Lee R . TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity. Diabetes. 2013; 62(6):2048-58. PMC: 3661629. DOI: 10.2337/db12-0931. View

Hell R, Silva Costa M, Goes A, Oliveira A . Local injection of BDNF producing mesenchymal stem cells increases neuronal survival and synaptic stability following ventral root avulsion. Neurobiol Dis. 2008; 33(2):290-300. DOI: 10.1016/j.nbd.2008.10.017. View

Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E . Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells. 2009; 27(10):2624-35. DOI: 10.1002/stem.194. View

Wei X, Zhao L, Zhong J, Gu H, Feng D, Johnstone B . Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett. 2009; 462(1):76-9. DOI: 10.1016/j.neulet.2009.06.054. View

Koliatsos V, Price W, Pardo C, Price D . Ventral root avulsion: an experimental model of death of adult motor neurons. J Comp Neurol. 1994; 342(1):35-44. DOI: 10.1002/cne.903420105. View

Xiao J, Zhang C, Zhang Y, Zhang X, Zhao J, Liang J . Transplantation of adipose-derived mesenchymal stem cells into a murine model of passive chronic immune thrombocytopenia. Transfusion. 2012; 52(12):2551-8. DOI: 10.1111/j.1537-2995.2012.03642.x. View

Farias A, Spagnol G, Bordeaux-Rego P, Oliveira C, Fontana A, de Paula R . Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE. CNS Neurosci Ther. 2013; 19(4):269-77. PMC: 6493393. DOI: 10.1111/cns.12071. View

10.

Lin C, Lin G, Lue T . Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev. 2012; 21(15):2770-8. PMC: 3806387. DOI: 10.1089/scd.2012.0176. View

11.

Semon J, Maness C, Zhang X, Sharkey S, Beuttler M, Shah F . Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis. Stem Cell Res Ther. 2014; 5(1):2. PMC: 4054950. DOI: 10.1186/scrt391. View

12.

Bassi E, Moraes-Vieira P, Moreira-Sa C, Almeida D, Vieira L, Cunha C . Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes. 2012; 61(10):2534-45. PMC: 3447906. DOI: 10.2337/db11-0844. View

13.

Oliveira A, Thams S, Lidman O, Piehl F, Hokfelt T, Karre K . A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. Proc Natl Acad Sci U S A. 2004; 101(51):17843-8. PMC: 539738. DOI: 10.1073/pnas.0408154101. View

14.

Li J, Ezzelarab M, Cooper D . Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation. 2012; 19(5):273-85. PMC: 3445044. DOI: 10.1111/xen.12000. View

15.

Lindroos B, Suuronen R, Miettinen S . The potential of adipose stem cells in regenerative medicine. Stem Cell Rev Rep. 2010; 7(2):269-91. DOI: 10.1007/s12015-010-9193-7. View

16.

Kim E, Kim N, Cho S . The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp Mol Med. 2013; 45:e2. PMC: 3584660. DOI: 10.1038/emm.2013.2. View

17.

Tobita M, Orbay H, Mizuno H . Adipose-derived stem cells: current findings and future perspectives. Discov Med. 2011; 11(57):160-70. View

18.

Abumaree M, Al Jumah M, Pace R, Kalionis B . Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev Rep. 2011; 8(2):375-92. DOI: 10.1007/s12015-011-9312-0. View

19.

Torres-Espin A, Corona-Quintanilla D, Fores J, Allodi I, Gonzalez F, Udina E . Neuroprotection and axonal regeneration after lumbar ventral root avulsion by re-implantation and mesenchymal stem cells transplant combined therapy. Neurotherapeutics. 2013; 10(2):354-68. PMC: 3625381. DOI: 10.1007/s13311-013-0178-5. View

20.

Taghi G, Ghasem Kashani Maryam H, Taghi L, Leili H, Leyla M . Characterization of in vitro cultured bone marrow and adipose tissue-derived mesenchymal stem cells and their ability to express neurotrophic factors. Cell Biol Int. 2012; 36(12):1239-49. DOI: 10.1042/CBI20110618. View